Clean Cells, a company founded in 2000, as the result of academic research, and an original member of Atlanpole Biotherapies,... View Article
Author Archives for Adeline Chauvigné
CLEAN CELLS® acquires BE VACCINES
10 May 2025Clean Cells, a company founded in 2000, as the result of academic research, and an original member of Atlanpole Biotherapies,... View Article
Valneva | 2018 Results and Growth in 2019
Valneva Reports Strong 2018 Results, Expects Further Growth and Major Pipeline Progression in 2019 Major R&D milestones achieved in 2018,... View Article
Valneva | 2018 Results and Growth in 2019
10 May 2025Valneva Reports Strong 2018 Results, Expects Further Growth and Major Pipeline Progression in 2019 Major R&D milestones achieved in 2018,... View Article
Clean Cells opened its capital to ArchiMed to support its growth strategy in the biopharmaceutical sector
The biopharmaceutical services company Clean Cells, specialized in biosafety testing and cell bank and virus seed stock production, has reached... View Article
Clean Cells opened its capital to ArchiMed to support its growth strategy in the biopharmaceutical sector
10 May 2025The biopharmaceutical services company Clean Cells, specialized in biosafety testing and cell bank and virus seed stock production, has reached... View Article
Emergent BioSolutions and Valneva Report Positive Phase 1 Results for their Vaccine Candidate Against the Zika Virus
EMERGENT BIOSOLUTIONS AND VALNEVA REPORT POSITIVE PHASE 1 RESULTS FOR THEIR VACCINE CANDIDATE AGAINST THE ZIKA VIRUS GAITHERSBURG, Md. and... View Article
Emergent BioSolutions and Valneva Report Positive Phase 1 Results for their Vaccine Candidate Against the Zika Virus
10 May 2025EMERGENT BIOSOLUTIONS AND VALNEVA REPORT POSITIVE PHASE 1 RESULTS FOR THEIR VACCINE CANDIDATE AGAINST THE ZIKA VIRUS GAITHERSBURG, Md. and... View Article
Telix Pharmaceuticals Completes Acquisition of Atlab Pharma
Telix Pharmaceuticals Limited (“Telix”, the “Company”) today announced the completion of the acquisition of Atlab Pharma SAS (“Atlab”). The option... View Article
Telix Pharmaceuticals Completes Acquisition of Atlab Pharma
10 May 2025Telix Pharmaceuticals Limited (“Telix”, the “Company”) today announced the completion of the acquisition of Atlab Pharma SAS (“Atlab”). The option... View Article
Samabriva and Affilogic entered into an Option and License Agreement to develop Nanofitin®-conjugated biotherapeutics to treat Lysosomal Storage Disorders
Amiens, France, and Nantes, France, September 10, 2018 – Samabriva and Affilogic jointly announced that they recently entered into an... View Article
Samabriva and Affilogic entered into an Option and License Agreement to develop Nanofitin®-conjugated biotherapeutics to treat Lysosomal Storage Disorders
10 May 2025Amiens, France, and Nantes, France, September 10, 2018 – Samabriva and Affilogic jointly announced that they recently entered into an... View Article
In-Cell-Art results with two Top 10 Pharma will be presented at the 16th Annual Discovery on Target on September 25-28 2018 in Boston
In-Cell-Art (ICA), a biotechnology company specialized in nanocarrier technologies named Nanotaxi® designed to unlock the promise of nucleic acids to... View Article
In-Cell-Art results with two Top 10 Pharma will be presented at the 16th Annual Discovery on Target on September 25-28 2018 in Boston
10 May 2025In-Cell-Art (ICA), a biotechnology company specialized in nanocarrier technologies named Nanotaxi® designed to unlock the promise of nucleic acids to... View Article
In-Cell-Art, the Institut Pasteur and BioNet-Asia announce the collaborative development of a dengue vaccine candidate successful in preclinical study
Nantes – Paris – France, 19th of June, 2018 – In-Cell-Art (ICA), a biotechnology company specialized in nanocarrier technologies, BioNet-Asia... View Article
In-Cell-Art, the Institut Pasteur and BioNet-Asia announce the collaborative development of a dengue vaccine candidate successful in preclinical study
10 May 2025Nantes – Paris – France, 19th of June, 2018 – In-Cell-Art (ICA), a biotechnology company specialized in nanocarrier technologies, BioNet-Asia... View Article
Bioregate Forum 2018 #2nd edition
Bioregate Forum is the “must attend” European gathering for key players in the Regenerative Medicine sector: 3 days dedicated to... View Article
Bioregate Forum 2018 #2nd edition
10 May 2025Bioregate Forum is the “must attend” European gathering for key players in the Regenerative Medicine sector: 3 days dedicated to... View Article
Affilogic is financing a proof of concept thanks to the Boost4Health programme
Affilogic,a member of Atlanpole Biotherapies, has received a € 5000 voucher as part of the Boost4Health programme. This support has... View Article
Affilogic is financing a proof of concept thanks to the Boost4Health programme
10 May 2025Affilogic,a member of Atlanpole Biotherapies, has received a € 5000 voucher as part of the Boost4Health programme. This support has... View Article